Basic aspects of the immunology of neuroinflammation

Inflammation in Psychiatry

Volumn 28, Issue , 2013, Pages 1-19

  Wohleb, Eric S ^a   Godbout, Jonathan P ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84925765559     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1159/000343964     Document Type: Chapter

References (153)

1. Lee YJ, Han SB, Nam SY, Oh KW, Hong JT: Inflammation and Alzheimer's disease. Arch Pharm Res 2010;33: 1539-1556.
2. Lee KS, Chung JH, Choi TK, Suh SY, Oh BH, et al: Peripheral cytokines and chemokines in Alzheimer's disease. Dement Geriatr Cogn Disord 2009;28:281-287.
3. Muir MT, Lovett-Racke AE, Racke MK: Novel therapeutic strategies targeting the pathogenic T-cells in multiple sclerosis. Expert Rev Clin Immunol 2005;1: 345-355.
4. Donnelly DJ, Popovich PG: Inflammation and its role in neuroprotection, axonal regeneration and functional recovery after spinal cord injury. Exp Neurol 2008;209:378-388.
5. McGavern DB, Kang SS: Illuminating viral infections in the nervous system. Nat Rev Immunol 2011;11:318-329.
6. Dantzer R, O'Connor JC, Freund GG, Johnson RW, Kelley KW: From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci 2008;9:46-56.
7. Dantzer R, Kelley KW: Twenty years of research on cytokine-induced sickness behavior. Brain Behav Immun 2007;21: 153-160.
8. Galea I, Bechmann I, Perry VH: What is immune privilege (not)? Trends Immunol 2007;28:12-18.
9. Fabry Z, Raine CS, Hart MN: Nervous tissue as an immune compartment: the dialect of the immune response in the CNS. Immunol Today 1994;15:218-224.
10. Hickey WF: Basic principles of immunological surveillance of the normal central nervous system. Glia 2001;36:118-124.
11. Stuve O, Marra CM, Bar-Or A, Niino M, Cravens PD, et al: Altered CD4+/CD8+ T-cell ratios in cerebrospinal fluid of natalizumab-treated patients with multiple sclerosis. Arch Neurol 2006;63: 1383-1387.
12. Hellwig K, Gold R: Progressive multifocal leukoencephalopathy and natalizumab. J Neurol 2011;258:1920-1928.
13. Stuve O, Gold R, Chan A, Mix E, Zettl U, et al: Alpha4-Integrin antagonism with natalizumab: effects and adverse effects. J Neurol 2008;255(suppl 6):58-65.
14. Carson MJ, Doose JM, Melchior B, Schmid CD, Ploix CC: CNS immune privilege: hiding in plain sight. Immunol Rev 2006;213:48-65.
15. Abbott NJ: Astrocyte-endothelial interactions and blood-brain barrier permeability. J Anat 2002;200:629-638.
16. Zlokovic BV: The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron 2008;57:178-201.
17. Ermisch A, Ruhle HJ, Landgraf R, Hess J: Blood-brain barrier and peptides. J Cereb Blood Flow Metab 1985;5:350-357.
18. Mathiisen TM, Lehre KP, Danbolt NC, Ottersen OP: The perivascular astroglial sheath provides a complete covering of the brain microvessels: an electron microscopic 3D reconstruction. Glia 2010;58:1094-1103.
19. Abbott NJ, Ronnback L, Hansson E: Astrocyte-endothelial interactions at the blood-brain barrier. Nat Rev Neurosci 2006;7:41-53.
20. Armulik A, Genove G, Mae M, Nisancioglu MH, Wallgard E, et al: Pericytes regulate the blood-brain barrier. Nature 2010;468:557-561.
21. Hickey WF, Kimura H: Perivascular microglial cells of the CNS are bone marrow-derived and present antigen in vivo. Science 1988;239:290-292.
22. Bechmann I, Galea I, Perry VH: What is the blood-brain barrier (not)? Trends Immunol 2007;28:5-11.
23. Wilson EH, Weninger W, Hunter CA: Trafficking of immune cells in the central nervous system. J Clin Invest 2010;120:1368-1379.
24. Greenwood J, Wang Y, Calder VL: Lymphocyte adhesion and transendothelial migration in the central nervous system: the role of LFA-1, ICAM-1, VLA-4 and VCAM-1. Immunology 1995;86:408-415.
25. Yong VW, Zabad RK, Agrawal S, Goncalves Dasilva A, Metz LM: Elevation of matrix metalloproteinases (MMPs) in multiple sclerosis and impact of immunomodulators. J Neurol Sci 2007;259:79-84.
26. Ransohoff RM, Cardona AE: The myeloid cells of the central nervous system parenchyma. Nature 2010;468:253-262.
27. Ginhoux F, Greter M, Leboeuf M, Nandi S, See P, et al: Fate mapping analysis reveals that adult microglia derive from primitive macrophages. Science 2010;330:841-845.
28. Tremblay ME, Stevens B, Sierra A, Wake H, Bessis A, et al: The role of microglia in the healthy brain. J Neurosci 2011;31:16064-16069.
29. Nimmerjahn A, Kirchhoff F, Helmchen F: Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science 2005;308: 1314-1318.
30. Grossmann R, Stence N, Carr J, Fuller L, Waite M, et al: Juxtavascular microglia migrate along brain microvessels following activation during early postnatal development. Glia 2002;37:229-240.
31. Rivest S: Regulation of innate immune responses in the brain. Nat Rev Immunol 2009;9:429-439.
32. Pocock JM, Kettenmann H: Neurotransmitter receptors on microglia. Trends Neurosci 2007;30:527-535.
33. Olson JK, Miller SD: Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs. J Immunol 2004;173:3916-3924.
34. de Haas AH, Boddeke HW, Biber K: Region-specific expression of immunoregulatory proteins on microglia in the healthy CNS. Glia 2008;56:888-894.
35. Aloisi F: Immune function of microglia. Glia 2001;36:165-179.
36. Davalos D, Grutzendler J, Yang G, Kim JV, Zuo Y, et al: ATP mediates rapid microglial response to local brain injury in vivo. Nat Neurosci 2005;8:752-758.
37. Garden GA, Moller T: Microglia biology in health and disease. J Neuroimmune Pharmacol 2006;1:127-137.
38. Ransohoff RM, Perry VH: Microglial physiology: unique stimuli, specialized responses. Annu Rev Immunol 2009;27: 119-145.
39. Jurgens HA, Johnson RW: Dysregulated neuronal-microglial cross-talk during aging, stress and inflammation. Exp Neurol 2012;233:40-48.
40. Dilger RN, Johnson RW: Aging, microglial cell priming, and the discordant central inflammatory response to signals from the peripheral immune system. J Leukoc Biol 2008;84:932-939.
41. Corona AW, Fenn AM, Godbout JP: Cognitive and behavioral consequences of impaired immunoregulation in aging. J Neuroimmune Pharmacol 2012;7: 7-23.
42. Henry CJ, Huang Y, Wynne AM, Godbout JP: Peripheral lipopolysaccharide (LPS) challenge promotes microglial hyperactivity in aged mice that is associated with exaggerated induction of both pro-inflammatory IL-1beta and antiinflammatory IL-10 cytokines. Brain Behav Immun 2009;23:309-317.
43. Wynne AM, Henry CJ, Huang Y, Cleland A, Godbout JP: Protracted downregulation of CX(3)CR1 on microglia of aged mice after lipopolysaccharide challenge. Brain Behav Immun 2010;24:1190-1201.
44. Godbout JP, Moreau M, Lestage J, Chen J, Sparkman NL, et al: Aging exacerbates depressive-like behavior in mice in response to activation of the peripheral innate immune system. Neuropsychopharmacology 2008;33:2341-2351.
45. Huang Y, Henry CJ, Dantzer R, Johnson RW, Godbout JP: Exaggerated sickness behavior and brain proinflammatory cytokine expression in aged mice in response to intracerebroventricular lipopolysaccharide. Neurobiol Aging 2008; 29:1744-1753.
46. Cardona AE, Pioro EP, Sasse ME, Kostenko V, Cardona SM, et al: Control of microglial neurotoxicity by the fractalkine receptor. Nat Neurosci 2006;9: 917-924.
47. Corona AW, Huang Y, O'Connor JC, Dantzer R, Kelley KW, et al: Fractalkine receptor (CX3CR1) deficiency sensitizes mice to the behavioral changes induced by lipopolysaccharide. J Neuroinflammation 2010;7:93.
48. Bechter K, Reiber H, Herzog S, Fuchs D, Tumani H, et al: Cerebrospinal fluid analysis in affective and schizophrenic spectrum disorders: identification of subgroups with immune responses and blood-CSF barrier dysfunction. J Psychiatr Res 2010;44:321-330.
49. Chen SK, Tvrdik P, Peden E, Cho S, Wu S, et al: Hematopoietic origin of pathological grooming in Hoxb8 mutant mice. Cell 2010;141:775-785.
50. Bechmann I, Priller J, Kovac A, Bontert M, Wehner T, et al: Immune surveillance of mouse brain perivascular spaces by blood-borne macrophages. Eur J Neurosci 2001;14:1651-1658.
51. Vallieres L, Sawchenko PE: Bone marrow-derived cells that populate the adult mouse brain preserve their hematopoietic identity. J Neurosci 2003;23:5197-5207.
52. Prinz M, Priller J, Sisodia SS, Ransohoff RM: Heterogeneity of CNS myeloid cells and their roles in neurodegeneration. Nat Neurosci 2011;14:1227-1235.
53. Schiltz JC, Sawchenko PE: Signaling the brain in systemic inflammation: the role of perivascular cells. Front Biosci 2003;8: s1321-s1329.
54. Serrats J, Schiltz JC, Garcia-Bueno B, van Rooijen N, Reyes TM, et al: Dual roles for perivascular macrophages in immune-to-brain signaling. Neuron 2010;65:94-106.
55. McMahon EJ, Bailey SL, Miller SD: CNS dendritic cells: critical participants in CNS inflammation? Neurochem Int 2006;49:195-203.
56. Prodinger C, Bunse J, Kruger M, Schiefenhovel F, Brandt C, et al: CD11cexpressing cells reside in the juxtavascular parenchyma and extend processes into the glia limitans of the mouse nervous system. Acta Neuropathol 2011; 121:445-458.
57. Bulloch K, Miller MM, Gal-Toth J, Milner TA, Gottfried-Blackmore A, et al: CD11c/EYFP transgene illuminates a discrete network of dendritic cells within the embryonic, neonatal, adult, and injured mouse brain. J Comp Neurol 2008;508:687-710.
58. Felger JC, Abe T, Kaunzner UW, Gottfried-Blackmore A, Gal-Toth J, et al: Brain dendritic cells in ischemic stroke: time course, activation state, and origin. Brain Behav Immun 2010;24:724-737.
59. Kaunzner UW, Miller MM, Gottfried-Blackmore A, Gal-Toth J, Felger JC, et al: Accumulation of resident and peripheral dendritic cells in the aging CNS. Neurobiol Aging 2012;33:681e1-693e1.
60. He F, Ge W, Martinowich K, Becker-Catania S, Coskun V, et al: A positive autoregulatory loop of Jak-STAT signaling controls the onset of astrogliogenesis. Nat Neurosci 2005;8:616-625.
61. Bonni A, Sun Y, Nadal-Vicens M, Bhatt A, Frank DA, et al: Regulation of gliogenesis in the central nervous system by the JAK-STAT signaling pathway. Science 1997;278:477-483.
62. Allen NJ, Barres BA: Neuroscience: Glia-more than just brain glue. Nature 2009;457:675-677.
63. Parpura V, Heneka MT, Montana V, Oliet SH, Schousboe A, et al: Glial cells in (patho)physiology. J Neurochem 2012; 121:4-27.
64. Anderson CM, Swanson RA: Astrocyte glutamate transport: review of properties, regulation, and physiological functions. Glia 2000;32:1-14.
65. Galic MA, Riazi K, Pittman QJ: Cytokines and brain excitability. Front Neuroendocrinol 2012;33:116-125.
66. Dong Y, Benveniste EN: Immune function of astrocytes. Glia 2001;36:180-190.
67. Sofroniew MV, Vinters HV: Astrocytes: biology and pathology. Acta Neuropathol 2010;119:7-35.
68. Pedersen A, Diedrich M, Kaestner F, Koelkebeck K, Ohrmann P, et al: Memory impairment correlates with increased S100B serum concentrations in patients with chronic schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2008;32:1789-1792.
69. Rothermundt M, Falkai P, Ponath G, Abel S, Burkle H, et al: Glial cell dysfunction in schizophrenia indicated by increased S100B in the CSF. Mol Psychiatry 2004;9:897-899.
70. Haydon PG, Carmignoto G: Astrocyte control of synaptic transmission and neurovascular coupling. Physiol Rev 2006;86:1009-1031.
71. Pascual O, Ben Achour S, Rostaing P, Triller A, Bessis A: Microglia activation triggers astrocyte-mediated modulation of excitatory neurotransmission. Proc Natl Acad Sci USA 2011;109:E197-E205.
72. Herrmann JE, Imura T, Song B, Qi J, Ao Y, et al: STAT3 is a critical regulator of astrogliosis and scar formation after spinal cord injury. J Neurosci 2008;28: 7231-7243.
73. Silver J, Miller JH: Regeneration beyond the glial scar. Nat Rev Neurosci 2004;5: 146-156.
74. Janeway CA Jr, Medzhitov R: Innate immune recognition. Annu Rev Immunol 2002;20:197-216.
75. Parker LC, Luheshi GN, Rothwell NJ, Pinteaux E: IL-1 beta signalling in glial cells in wildtype and IL-1RI deficient mice. Br J Pharmacol 2002;136:312-320.
76. Lawrence T: The nuclear factor NFkappaB pathway in inflammation. Cold Spring Harb Perspect Biol 2009;1: a001651.
77. Lazarus M, Yoshida K, Coppari R, Bass CE, Mochizuki T, et al: EP3 prostaglandin receptors in the median preoptic nucleus are critical for fever responses. Nat Neurosci 2007;10:1131-1133.
78. Ericsson A, Arias C, Sawchenko PE: Evidence for an intramedullary prostaglandin-dependent mechanism in the activation of stress-related neuroendocrine circuitry by intravenous interleukin-1. J Neurosci 1997;17:7166-7179.
79. Anthony DC, Couch Y, Losey P, Evans MC: The systemic response to brain injury and disease. Brain Behav Immun 2012;26:534-540.
80. Saha RN, Pahan K: Regulation of inducible nitric oxide synthase gene in glial cells. Antioxid Redox Signal 2006;8: 929-947.
81. Paakkari I, Lindsberg P: Nitric oxide in the central nervous system. Ann Med 1995;27:369-377.
82. Strle K, Zhou JH, Shen WH, Broussard SR, Johnson RW, et al: Interleukin-10 in the brain. Crit Rev Immunol 2001;21: 427-449.
83. Baker BJ, Akhtar LN, Benveniste EN: SOCS1 and SOCS3 in the control of CNS immunity. Trends Immunol 2009;30: 392-400.
84. Cardona AE, Li M, Liu L, Savarin C, Ransohoff RM: Chemokines in and out of the central nervous system: much more than chemotaxis and inflammation. J Leukoc Biol 2008;84:587-594.
85. El Khoury J, Toft M, Hickman SE, Means TK, Terada K, et al: Ccr2 deficiency impairs microglial accumulation and accelerates progression of Alzheimerlike disease. Nat Med 2007;13:432-438.
86. D'Mello C, Le T, Swain MG: Cerebral microglia recruit monocytes into the brain in response to tumor necrosis factor-alpha signaling during peripheral organ inflammation. J Neurosci 2009;29: 2089-2102.
87. Prinz M, Priller J: Tickets to the brain: role of CCR2 and CX3CR1 in myeloid cell entry in the CNS. J Neuroimmunol 2010;224:80-84.
88. Auffray C, Fogg D, Garfa M, Elain G, Join-Lambert O, et al: Monitoring of blood vessels and tissues by a population of monocytes with patrolling behavior. Science 2007;317:666-670.
89. Myint AM, Kim YK: Cytokine-serotonin interaction through IDO: a neurodegeneration hypothesis of depression. Med Hypoth 2003;61:519-525.
90. Stone TW, Darlington LG: Endogenous kynurenines as targets for drug discovery and development. Nat Rev Drug Discov 2002;1:609-620.
91. Muller N, Schwarz MJ: The immunemediated alteration of serotonin and glutamate: towards an integrated view of depression. Mol Psychiatry 2007;12: 988-1000.
92. Leonard BE, Myint A: The psychoneuroimmunology of depression. Hum Psychopharmacol 2009;24:165-175.
93. Raison CL, Capuron L, Miller AH: Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol 2006;27:24-31.
94. Haroon E, Raison CL, Miller AH: Psychoneuroimmunology meets neuropsychopharmacology: translational implications of the impact of inflammation on behavior. Neuropsychopharmacology 2012;37:137-162.
95. O'Connor JC, Lawson MA, Andre C, Moreau M, Lestage J, et al: Lipopolysaccharide-induced depressivelike behavior is mediated by indoleamine 2,3-dioxygenase activation in mice. Mol Psychiatry 2009;14:511-522.
96. Myint AM, Kim YK, Verkerk R, Scharpe S, Steinbusch H, et al: Kynurenine pathway in major depression: evidence of impaired neuroprotection. J Affect Disord 2007;98:143-151.
97. Quan N, Banks WA: Brain-immune communication pathways. Brain Behav Immun 2007;21:727-735.
98. Kent S, Bret-Dibat JL, Kelley KW, Dantzer R: Mechanisms of sicknessinduced decreases in food-motivated behavior. Neurosci Biobehav Rev 1996;20:171-175.
99. Konsman JP, Parnet P, Dantzer R: Cytokine-induced sickness behaviour: mechanisms and implications. Trends Neurosci 2002;25:154-159.
100. Maier SF, Watkins LR: Cytokines for psychologists: implications of bidirectional immune-to-brain communication for understanding behavior, mood, and cognition. Psychol Rev 1998;105:83-107.
101. Kluger MJ, Rothenburg BA: Fever and reduced iron: their interaction as a host defense response to bacterial infection. Science 1979;203:374-376.
102. Benarroch EE: Circumventricular organs: receptive and homeostatic functions and clinical implications. Neurology 2011;77:1198-1204.
103. Goehler LE, Erisir A, Gaykema RP: Neural-immune interface in the rat area postrema. Neuroscience 2006;140:1415-1434.
104. Quan N: Immune-to-brain signaling: how important are the blood-brain barrier-independent pathways? Mol Neurobiol 2008;37:142-152.
105. Ching S, He L, Lai W, Quan N: IL-1 type I receptor plays a key role in mediating the recruitment of leukocytes into the central nervous system. Brain Behav Immun 2005;19:127-137.
106. Pinteaux E, Parker LC, Rothwell NJ, Luheshi GN: Expression of interleukin-1 receptors and their role in interleukin-1 actions in murine microglial cells. J Neurochem 2002;83:754-763.
107. Marvel FA, Chen CC, Badr N, Gaykema RP, Goehler LE: Reversible inactivation of the dorsal vagal complex blocks lipopolysaccharide-induced social withdrawal and c-Fos expression in central autonomic nuclei. Brain Behav Immun 2004;18:123-134.
108. Konsman JP, Luheshi GN, Bluthe RM, Dantzer R: The vagus nerve mediates behavioural depression, but not fever, in response to peripheral immune signals; a functional anatomical analysis. Eur J Neurosci 2000;12:4434-4446.
109. Goehler LE, Gaykema RP, Hammack SE, Maier SF, Watkins LR: Interleukin-1 induces c-Fos immunoreactivity in primary afferent neurons of the vagus nerve. Brain Res 1998;804:306-310.
110. Goehler LE, Relton JK, Dripps D, Kiechle R, Tartaglia N, et al: Vagal paraganglia bind biotinylated interleukin-1 receptor antagonist: a possible mechanism for immune-to-brain communication. Brain Res Bull 1997;43:357-364.
111. Luheshi GN, Bluthe RM, Rushforth D, Mulcahy N, Konsman JP, et al: Vagotomy attenuates the behavioural but not the pyrogenic effects of interleukin-1 in rats. Auton Neurosci 2000;85:127-132.
112. Engler H, Doenlen R, Engler A, Riether C, Prager G, et al: Acute amygdaloid response to systemic inflammation. Brain Behav Immun 2011;25:1384-1392.
113. Hinwood M, Morandini J, Day TA, Walker FR: Evidence that microglia mediate the neurobiological effects of chronic psychological stress on the medial prefrontal cortex. Cereb Cortex 2012;22:1442-1454.
114. Tynan RJ, Naicker S, Hinwood M, Nalivaiko E, Buller KM, et al: Chronic stress alters the density and morphology of microglia in a subset of stress-responsive brain regions. Brain Behav Immun 2010;24:1058-1068.
115. Wohleb ES, Hanke ML, Corona AW, Powell ND, Stiner LM, et al: Betaadrenergic receptor antagonism prevents anxiety-like behavior and microglial reactivity induced by repeated social defeat. J Neurosci 2011;31:6277-6288.
116. Morilak DA, Barrera G, Echevarria DJ, Garcia AS, Hernandez A, et al: Role of brain norepinephrine in the behavioral response to stress. Prog Neuropsychopharmacol Biol Psychiatry 2005;29: 1214-1224.
117. Shin LM, Liberzon I: The neurocircuitry of fear, stress, and anxiety disorders. Neuropsychopharmacology 2010;35: 169-191.
118. Yirmiya R, Goshen I: Immune modulation of learning, memory, neural plasticity and neurogenesis. Brain Behav Immun 2011;25:181-213.
119. Lucin KM, Wyss-Coray T: Immune activation in brain aging and neurodegeneration: too much or too little? Neuron 2009;64:110-122.
120. Villeda SA, Luo J, Mosher KI, Zou B, Britschgi M, et al: The ageing systemic milieu negatively regulates neurogenesis and cognitive function. Nature 2011;477: 90-94.
121. Palmer TD, Willhoite AR, Gage FH: Vascular niche for adult hippocampal neurogenesis. J Comp Neurol 2000;425: 479-494.
122. Carmeliet P: Blood vessels and nerves: common signals, pathways and diseases. Nat Rev Genet 2003;4:710-720.
123. Belevych N, Buchanan K, Chen Q, Bailey M, Quan N: Location-specific activation of the paraventricular nucleus of the hypothalamus by localized inflammation. Brain Behav Immun 2010;24: 1137-1147.
124. Rosas-Ballina M, Tracey KJ: The neurology of the immune system: neural reflexes regulate immunity. Neuron 2009;64:28-32.
125. Webster JI, Tonelli L, Sternberg EM: Neuroendocrine regulation of immunity. Annu Rev Immunol 2002;20:125-163.
126. Sternberg EM: Neural regulation of innate immunity: a coordinated nonspecific host response to pathogens. Nat Rev Immunol 2006;6:318-328.
127. Munhoz CD, Sorrells SF, Caso JR, Scavone C, Sapolsky RM: Glucocorticoids exacerbate lipopolysaccharide-induced signaling in the frontal cortex and hippocampus in a dose-dependent manner. J Neurosci 2010;30:13690-13698.
128. Sorrells SF, Sapolsky RM: An inflammatory review of glucocorticoid actions in the CNS. Brain Behav Immun 2007;21: 259-272.
129. Frank MG, Baratta MV, Sprunger DB, Watkins LR, Maier SF: Microglia serve as a neuroimmune substrate for stressinduced potentiation of CNS proinflammatory cytokine responses. Brain Behav Immun 2007;21:47-59.
130. Sorrells SF, Sapolsky RM: Glucocorticoids can arm macrophages for innate immune battle. Brain Behav Immun 2010;24:17-18.
131. Trottier MD, Newsted MM, King LE, Fraker PJ: Natural glucocorticoids induce expansion of all developmental stages of murine bone marrow granulocytes without inhibiting function. Proc Natl Acad Sci USA 2008;105:2028-2033.
132. Engler H, Engler A, Bailey MT, Sheridan JF: Tissue-specific alterations in the glucocorticoid sensitivity of immune cells following repeated social defeat in mice. J Neuroimmunol 2005;163:110-119.
133. Engler H, Bailey MT, Engler A, Sheridan JF: Effects of repeated social stress on leukocyte distribution in bone marrow, peripheral blood and spleen. J Neuroimmunol 2004;148:106-115.
134. Kinsey SG, Bailey MT, Sheridan JF, Padgett DA: The inflammatory response to social defeat is increased in older mice. Physiol Behav 2008;93:628-636.
135. Wohleb ES, Fenn AM, Pacenta AM, Powell ND, Sheridan JF, et al: Peripheral innate immune challenge exaggerated microglia activation, increased the number of inflammatory CNS macrophages, and prolonged social withdrawal in socially defeated mice. Psychoneuroendocrinology 2012;37:1491-1505.
136. Felten DL, Felten SY, Carlson SL, Olschowka JA, Livnat S: Noradrenergic and peptidergic innervation of lymphoid tissue. J Immunol 1985;135:755s-765s.
137. Nance DM, Sanders VM: Autonomic innervation and regulation of the immune system (1987-2007). Brain Behav Immun 2007;21:736-745.
138. Meltzer JC, MacNeil BJ, Sanders V, Pylypas S, Jansen AH, et al: Stressinduced suppression of in vivo splenic cytokine production in the rat by neural and hormonal mechanisms. Brain Behav Immun 2004;18:262-273.
139. Miller GE, Chen E, Sze J, Marin T, Arevalo JM, et al: A functional genomic fingerprint of chronic stress in humans: blunted glucocorticoid and increased NF-kappaB signaling. Biol Psychiatry 2008;64:266-272.
140. Miller GE, Chen E, Fok AK, Walker H, Lim A, et al: Low early-life social class leaves a biological residue manifested by decreased glucocorticoid and increased proinflammatory signaling. Proc Natl Acad Sci USA 2009;106:14716-14721.
141. Cole SW, Arevalo JM, Takahashi R, Sloan EK, Lutgendorf SK, et al: Computational identification of gene-social environment interaction at the human IL-6 locus. Proc Natl Acad Sci USA 2010;107: 5681-5686.
142. Spiegel A, Shivtiel S, Kalinkovich A, Ludin A, Netzer N, et al: Catecholaminergic neurotransmitters regulate migration and repopulation of immature human CD34+ cells through Wnt signaling. Nat Immunol 2007;8:1123-1131.
143. Johnson JD, Cortez V, Kennedy SL, Foley TE, Hanson H 3rd, et al: Role of central beta-adrenergic receptors in regulating proinflammatory cytokine responses to a peripheral bacterial challenge. Brain Behav Immun 2008;22:1078-1086.
144. Johnson JD, Campisi J, Sharkey CM, Kennedy SL, Nickerson M, et al: Catecholamines mediate stress-induced increases in peripheral and central inflammatory cytokines. Neuroscience 2005;135:1295-1307.
145. Audet MC, Jacobson-Pick S, Wann BP, Anisman H: Social defeat promotes specific cytokine variations within the prefrontal cortex upon subsequent aggressive or endotoxin challenges. Brain Behav Immun 2011;25:1197-1205.
146. Anisman H, Merali Z: Anhedonic and anxiogenic effects of cytokine exposure. Adv Exp Med Biol 1999;461:199-233.
147. Krishnan V, Han MH, Graham DL, Berton O, Renthal W, et al: Molecular adaptations underlying susceptibility and resistance to social defeat in brain reward regions. Cell 2007;131:391-404.
148. O'Donovan A, Neylan TC, Metzler T, Cohen BE: Lifetime exposure to traumatic psychological stress is associated with elevated inflammation in the Heart and Soul Study. Brain Behav Immun 2012;26:642-649.
149. Kiecolt-Glaser JK, Glaser R: Depression and immune function: central pathways to morbidity and mortality. J Psychosom Res 2002;53:873-876.
150. Kiecolt-Glaser JK, Preacher KJ, MacCallum RC, Atkinson C, Malarkey WB, et al: Chronic stress and age-related increases in the proinflammatory cytokine IL-6. Proc Natl Acad Sci USA 2003; 100:9090-9095.
151. Glaser R, Kiecolt-Glaser JK: Stressinduced immune dysfunction: implications for health. Nat Rev Immunol 2005;5:243-251.
152. Suarez EC, Krishnan RR, Lewis JG: The relation of severity of depressive symptoms to monocyte-associated proinflammatory cytokines and chemokines in apparently healthy men. Psychosom Med 2003;65:362-368.
153. Suarez EC, Lewis JG, Krishnan RR, Young KH: Enhanced expression of cytokines and chemokines by blood monocytes to in vitro lipopolysaccharide stimulation are associated with hostility and severity of depressive symptoms in healthy women. Psychoneuroendocrinology 2004;29:1119-1128.